Home » Newsletters » BioWorld

BioWorld

Oct. 29, 1991

View Archived Issues

IVAX SHAREHOLDERS OK 3-2 STOCK SPLIT

NORTH AMERICAN TO COLLABORATE WITH HARVARD

FDA CLEARS BAINBRIDGE'S H. PYLORI TEST

QUEST TO PRODUCE ESCAGENETICS FLAVORINGS

GENZYME REPORTS PROFITABLE QUARTER

LEGAL WOES CONTRIBUTE TO COLLAGEN LOSS

GENENTECH WINS MARKET EXCLUSIVITY IN JAPAN

JURY RULES FOR XOMA IN PATENT DISPUTE

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...